Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITDAEPS (Basic)EPS (Weighted Average and Diluted)Interest & Investment IncomeInterest ExpensesInterest ExpensesNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Achieve Life Sciences (ACHV) EPS (Basic) (2016 - 2026)

Achieve Life Sciences (ACHV) has disclosed EPS (Basic) for 17 consecutive years, with -$0.19 as the latest value for Q1 2026.

  • Quarterly EPS (Basic) rose 48.65% to -$0.19 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.1 through Mar 2026, up 17.91% year-over-year, with the annual reading at -$1.25 for FY2025, 0.81% down from the prior year.
  • EPS (Basic) for Q1 2026 was -$0.19 at Achieve Life Sciences, up from -$0.26 in the prior quarter.
  • The five-year high for EPS (Basic) was -$0.19 in Q1 2026, with the low at -$1.35 in Q3 2022.
  • Average EPS (Basic) over 5 years is -$0.48, with a median of -$0.36 recorded in 2024.
  • The sharpest move saw EPS (Basic) crashed 90.14% in 2022, then soared 74.81% in 2023.
  • Achieve Life Sciences' EPS (Basic) stood at -$0.76 in 2022, then skyrocketed by 68.42% to -$0.24 in 2023, then plummeted by 50.0% to -$0.36 in 2024, then rose by 27.78% to -$0.26 in 2025, then rose by 26.92% to -$0.19 in 2026.
  • Per Business Quant, the three most recent readings for ACHV's EPS (Basic) are -$0.19 (Q1 2026), -$0.26 (Q4 2025), and -$0.28 (Q3 2025).